New Advances in Atrial Fibrillation Management: The Role of Apixaban

E-ISSN： 1873-5592|19|6|585-592

ISSN： 1389-4501

Source： Current Drug Targets, Vol.19, Iss.6, 2018-04, pp. : 585-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

More light at the end of the tunnel – apixaban in atrial fibrillation

By Doggrell Sheila A

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1235-1239

Informa Healthcare

Access to resources Recommend Favorite

Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban

By Giorgi Mariano A Cohen Arazi Hernáán Gonzalez Claudio D Di Girolamo Guillermo

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 567-577

Informa Healthcare

Access to resources Recommend Favorite

Modern management of atrial fibrillation

By Watson Timothy Shanstila Eduard Lip Gregory YH

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 28-34

Royal College Of Physicians

Access to resources Recommend Favorite

The management of atrial fibrillation

By Davies Wyn

Clinical Medicine, Vol. 1, Iss. 3, 2001-05 ,pp. : 190-193

Royal College Of Physicians

Access to resources Recommend Favorite

New Approaches to Atrial Fibrillation Management: A Critical Review of a Rapidly Evolving Field

By Nattel S.

Drugs, Vol. 62, Iss. 16, 2002-01 ,pp. : 2377-2397

Adis International

Access to resources Recommend Favorite